(Q45918376)

17 December 2017

title

Felodipine downregulates serum interleukin-18 levels in rats with fructose-induced metabolic syndrome. (English)

1 reference

17 December 2017

1 reference

X-P Bi

1

1 reference

17 December 2017

H-W Tan

2

1 reference

17 December 2017

S-S Xing

3

1 reference

17 December 2017

M Zhong

4

1 reference

17 December 2017

Y Zhang

5

1 reference

17 December 2017

W Zhang

6

1 reference

17 December 2017

publication date

1 April 2009

1 reference

17 December 2017

Journal of Endocrinological Investigation

published in

1 reference

17 December 2017

volume

32

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

303-307

1 reference

17 December 2017

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

The anti-inflammatory effect of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

"Anti-inflammatory" drugs and their effects on type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Are calcium antagonists beneficial in diabetic patients with hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Weight loss reduces interleukin-18 levels in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Effects of enalapril on the vascular wall in an experimental model of syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Interleukin-18 and host defense against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Dysfunction of endothelial nitric oxide synthase and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345716

TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation

21 January 2018

1 reference

12 December 2020

Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease

1 reference

12 December 2020

Effect of amlodipine on insulin resistance & tumor necrosis factor-alpha levels in hypertensive obese type 2 diabetic patients.

1 reference

12 December 2020

Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro

1 reference

12 December 2020

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345716

1 reference

17 December 2017

Dimensions Publication ID

1008818913

0 references

1 reference

17 December 2017